The world’s biggest drugmaker Eli Lilly has forecast that profits for the year will beat expectations, after two choppy quarters when disappointing sales of its blockbuster weight-loss drugs led to ...

Moreover, the SNB has other tools in its armoury, such as outright currency interventions to weaken the Swiss franc. Morgan Stanley reckons that Switzerland’s central bank will continue to defend the ...